Showing results (51-60 of 101) with videos related to
Sort By:
Pageof 11
British Journal of Haematology|April 11, 2016
Central nervous system involvement in AIDS-related lymphomasStefan K Barta, Jitesh Joshi, Nicolas Mounier, et al.Journal of the National Cancer Institute|January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell LymphomaStephen E Spurgeon, Brian G Till, Peter Martin, et al.Journal of Geriatric Oncology|October 23, 2021
SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas - Aiming to improve therapy, outcomes, and validate a prospective frailty toolElizabeth A Brem, Hongli Li, Anne W Beaven, et al.Journal of the National Cancer Institute. Monographs|December 15, 2022
Trial Design Considerations to Increase Older Adult Accrual to National Cancer Institute Clinical TrialsJennifer Le-Rademacher, Supriya Mohile, Joseph Unger, et al.Journal of the National Cancer Institute|December 18, 2016
General Biomarker Recommendations for LymphomaLisa Rimsza, Yuri Fedoriw, Louis M Staudt, et al.Journal of the National Cancer Institute|January 2, 2017
Hodgkin Lymphoma: Current Status and Clinical Trial RecommendationsCatherine S Diefenbach, Joseph M Connors, Jonathan W Friedberg, et al.Cancer|January 30, 2014
A phase 1/pharmacokinetic study of sunitinib in combination with highly active antiretroviral therapy in human immunodeficiency virus-positive patients with cancer: AIDS Malignancy Consortium trial AMC 061Michelle A Rudek, Page C Moore, Ronald T Mitsuyasu, et al.Blood Cancer Journal|June 29, 2022
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering CommitteeShaji Kumar, Lawrence Baizer, Natalie S Callander, et al.The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.JAMA Oncology|January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology PracticesScott D Ramsey, Joseph M Unger, Laurence H Baker, et al.Pageof 11